Supreme Court to rule on drug warning labels

0 Shares

Drug warning labels are under legal scrutinyOn Monday, attorneys for the Bush administration argued in front of the Supreme Court that drug companies should be shielded from consumer lawsuits even if they fail to warn patients about risks which could have long reaching effects on their health.

The case involves Diana Levine, a Vermont woman who had her arm amputated after an IV push of the anti-nausea medication Phenergan struck an artery, causing gangrene.

A jury awarded Levine $6.7 million in her suit against Wyeth, the drug’s maker, which the company appealed claiming the federal Food, Drug and Cosmetic Act prevents state lawsuits that conflict with federal drug regulations like warning labels approved by the U.S. Food and Drug Administration.

Levine’s lawyer, David Frederick, argued that Wyeth didn’t do everything in its power to warn of the potential dangers.

"The manufacturer has a duty of due care, a duty to analyze new information on risk and to make appropriate change in the warning to reflect that," said Frederick. "It didn’t live up to that duty."

According to Wyeth’s website, Phenergan has been on the market since 1951 and is typically used to treat the effects of inhaled allergens or food allergies.

ADNFCR-1961-ID-18863148-ADNFCR

Personal Liberty News Desk

Join the Discussion

Comment Policy: We encourage an open discussion with a wide range of viewpoints, even extreme ones, but we will not tolerate racism, profanity or slanderous comments toward the author(s) or comment participants. Make your case passionately, but civilly. Please don't stoop to name calling. We use filters for spam protection. If your comment does not appear, it is likely because it violates the above policy or contains links or language typical of spam. We reserve the right to remove comments at our discretion.